A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172) (vol 52, pg 394, 2011)

作者:Kouroukis C Tom*; Fernandez Louis A V; Crump Michael; Gascoyne Randy D; Chua Neil Sun; Buckstein Rena; Turner Robert; Assouline Sarit; K**** Richard J; Walsh Wendy; Powers Jean; Eisenhauer Elizabeth
来源:Leukemia and Lymphoma, 2011, 52(6): 1160-1160.
DOI:10.3109/10428194.2011.578973